伴随性病理及其对渐进性上核性麻的影响:当前观点
1Institute of Clinical Neurobiology, Alberichgasse 5/13, Vienna, 1150, Austria. kurt.jellinger@univie.ac.at.
Journal of neural transmission (Vienna, Austria : 1996)
|August 12, 2025
概括
渐进性超核性麻 (PSP) 通常与其他神经退行性或全身性疾病一起出现. 了解这些共同病理对于改善患者护理和临床试验设计至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经病理学神经病理学
背景情况:
- 渐进性超核性麻 (PSP) 是一种有特定临床和形态特征的病.
- 孤立的PSP神经病理很少见,大约70%的病例表现出共同的神经病理.
研究的目的:
- 讨论PSP患者共同病理的频率和临床影响.
- 为改善治疗策略提供对病原性背景的洞察力.
主要方法:
- 审查现有的关于PSP共病症和共病症的文献.
- 对伴随性疾病的临床影响和病原机制的分析.
主要成果:
- 在其他疾病中,PSP经常与阿尔茨海默氏症类型,莱维体和TDP-43病理发生.
- 常见的并发病包括高血压,心血管疾病和糖尿病.
结论:
- 同病症和并发症显著影响PSP的进展和结果.
- 对PSP的临床试验必须在设计和患者选择中考虑这些因素,以获得更好的治疗结果.
相关概念视频
Parkinson's Disease: Overview
704
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
704
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
957
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
957
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Neural Regulation
40.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.0K
COPD: Pathogenesis and Clinical Features
521
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
521
Alzheimer's Disease: Overview
668
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
668


